Federal grant · project grant (b)
Spatial Genomics Analysis of Tumor Samples - Summary Imaging the Tumor Microenvironment (TME) Is Key to Understanding Tumor Growth, Disease Progression and Therapy Options. the Tme Often Consists of a Complex Neighborhood of Diverse Populations of Immune Cells, Fibroblasts, and Tumors Cells. Little Is Known About the “geography” of the Tumors and the Spatial Organization of the Distinct Cell Types. the Ability to Rapidly Identify Different Cell Types and Tumor Subtypes Using Molecular Markers Will Be Transformative for Cancer Diagnostics. at Spatial Genomics, We Are Commercializing Technology That Allows Transcript Profiling in Tumor Samples. With This Technology, Cell Types in Situ and Spatial Organizations Can Be Directly Identified and Visualized in Tumor Tissue Slices. These Capabilities Provide a Powerful Tool for Examining the Different Cell Types and Their Interactions in the Tumor Microenvironment. in This Proposal, We Will Develop the Reagents, Instrumentation, and the Associated Software That Will Allow Researchers to Perform Spatial Mapping Experiments in Tumor Slices.
Committed
$2.0 Million
Paid out
$1.9M
97%
Committed, not yet paid
$58.8K
3%
Everything here is this single award's whole record — signed, amended, paid — not a fiscal-year slice. The by-year charts elsewhere split an award across the years it was committed; this page keeps it whole.
Committed is what the government has legally promised on this award so far. Contracts can also carry a ceiling — the maximum if every option is exercised. Unspent ceiling is headroom, not money owed.
The cash actually disbursed against this award. The gap from committed is the disbursement pipeline: promised, not yet cashed.
Each transaction is a signing event — an action that created or changed the award, dated the day it was signed — not a payment. Negative amounts are real: money de-committed at closeout or renegotiation.
One bar, the award’s whole arithmetic: paid out, then committed, not yet paid, then .
Loading…